Guidelines

A-106 DABIGATRAN ETEXILATE IN THE TREATMENT OF LOCALIZED INTRAVASCULAR COAGULOPATHY ASSOCIATED WITH VENOUS MALFORMATIONS

February 2018
A-133 EFFECT OF ABCB1 GENETIC POLYMORPHISMS ON THE TRANSPORT OF RIVAROXABAN IN HEK293 RECOMBINANT CELL LINES

February 2018
A-147 DIAGNOSTIC PERFORMANCE EVALUATION OF QUANTIA D-DIMER® REAGENT FOR PULMONARY EMBOLISM IN CLINICAL PRACTICE

February 2018
O1 Prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation in high risk acute leukemia and myelodysplastic syndromes: a single-center retrospective study.

February 2018
O2 In Vitro Effects of BCR-ABL Tyrosine Kinase Inhibitors on Endothelial Cells Survival and Functions

February 2018
O3 Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis

February 2018
O4 Modeling T cell acute lymphoblastic leukemia using CRISPR/Cas9 mediated genome editing in Xenopus tropicalis

February 2018
O5 Inhibition of multiple myeloma exosomes prevents bone loss and reduces tumor growth.

February 2018
O6 Analysis of the impact of mismatches at HLA loci DRB3/4/5 on outcomes after allogeneic stem cell transplantation

February 2018
PP01 Exploring the long non-coding RNA landscape in Juvenile Myelomonocytic Leukemia

February 2018

Top